NCT03213691

Clinical Trial Information


Trial Number: NCT03213691 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Astrocytoma, High Grade
  • CNS Neoplasm (Primary Tumor) - Astrocytoma, Low Grade
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Soft Tissue Neoplasm - Rhabdomyosarcoma
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial"
Study ID:
APEC1621E
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®